Neurocrine Biosciences (NBIX) P/E (2010 - 2026)
Neurocrine Biosciences (NBIX) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Neurocrine Biosciences (NBIX) P/E is 24.68. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Neurocrine Biosciences (NBIX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 24.68 | -16.43% |
| 2025 | 29.53 | -26.54% |
| 2024 | 40.20 | -40.16% |
| 2023 | 67.18 | -65.99% |
| 2022 | 197.54 | +119.70% |
| 2021 | 89.91 | +309.11% |
| 2020 | 21.98 | -91.93% |
| 2019 | 272.34 | -12.98% |
| 2018 | 312.96 | -993.27% |
| 2017 | -35.04 | +31.38% |
| 2016 | -26.67 | -51.24% |
| 2015 | -54.69 | +94.72% |
| 2014 | -28.09 | +106.56% |
| 2013 | -13.60 | -113.72% |
| 2012 | 99.12 | +764.52% |
| 2011 | 11.47 | -106.98% |
| 2010 | -164.29 | N/A |
Comparison Neurocrine Biosciences (NBIX) P/E with competitors
Neurocrine Biosciences (NBIX) P/E is 24.68.